α1-Adrenergic Receptor Antagonists: Novel Therapy for Pituitary Adenomas

Manory A. Fernando, Anthony P. Heaney
2005 Molecular Endocrinology  
Pituitary tumors are common and cause considerable morbidity due to local invasion and altered hormone secretion. Doxazosin (dox), a selective ␣ 1 -adrenergic receptor antagonist, used to treat hypertension, also inhibits prostate cancer cell proliferation. We examined the effects of dox on murine and human pituitary tumor cell proliferation in vitro and in vivo. dox treatment inhibited proliferation of murine pituitary tumor cells, induced G 0 -G 1 cell cycle arrest, and reduced phosphorylated
more » ... retinoblastoma levels. In addition, increased annexin-fluorescein isothiocyanate immunoreactivity and cleaved caspase-3 levels, in keeping with dox-mediated apoptosis, were observed in the human and murine pituitary tumor cells, and dox administration to mice, harboring corticotroph tumors, decreased tumor growth and reduced plasma ACTH levels. dox-mediated antiprolifera-
doi:10.1210/me.2004-0471 pmid:16020484 fatcat:jkpnnffbqjhz5l7eusymbj6fjq